全文获取类型
收费全文 | 62595篇 |
免费 | 4404篇 |
国内免费 | 1449篇 |
专业分类
耳鼻咽喉 | 169篇 |
儿科学 | 1437篇 |
妇产科学 | 774篇 |
基础医学 | 4577篇 |
口腔科学 | 547篇 |
临床医学 | 7748篇 |
内科学 | 19741篇 |
皮肤病学 | 297篇 |
神经病学 | 1028篇 |
特种医学 | 941篇 |
外国民族医学 | 1篇 |
外科学 | 7382篇 |
综合类 | 9799篇 |
现状与发展 | 3篇 |
预防医学 | 3349篇 |
眼科学 | 146篇 |
药学 | 5688篇 |
53篇 | |
中国医学 | 3198篇 |
肿瘤学 | 1570篇 |
出版年
2024年 | 120篇 |
2023年 | 1118篇 |
2022年 | 1979篇 |
2021年 | 2839篇 |
2020年 | 2724篇 |
2019年 | 2249篇 |
2018年 | 2152篇 |
2017年 | 2138篇 |
2016年 | 2144篇 |
2015年 | 2300篇 |
2014年 | 4470篇 |
2013年 | 4590篇 |
2012年 | 3523篇 |
2011年 | 4171篇 |
2010年 | 3153篇 |
2009年 | 3100篇 |
2008年 | 3026篇 |
2007年 | 3090篇 |
2006年 | 2784篇 |
2005年 | 2506篇 |
2004年 | 1937篇 |
2003年 | 1703篇 |
2002年 | 1386篇 |
2001年 | 1292篇 |
2000年 | 958篇 |
1999年 | 855篇 |
1998年 | 684篇 |
1997年 | 637篇 |
1996年 | 604篇 |
1995年 | 519篇 |
1994年 | 532篇 |
1993年 | 370篇 |
1992年 | 330篇 |
1991年 | 327篇 |
1990年 | 283篇 |
1989年 | 288篇 |
1988年 | 273篇 |
1987年 | 193篇 |
1986年 | 168篇 |
1985年 | 170篇 |
1984年 | 151篇 |
1983年 | 79篇 |
1982年 | 103篇 |
1981年 | 86篇 |
1980年 | 73篇 |
1979年 | 72篇 |
1978年 | 52篇 |
1977年 | 40篇 |
1976年 | 43篇 |
1974年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
《Annals of hepatology》2019,18(3):514-516
Gyromitra esculenta, also known as “false morel” is one of the most poisonous mushrooms. This species is found all over the world, growing in coniferous forest in early spring time. Common manifestation of poisoning includes gastrointestinal symptoms which include varied degrees of liver impairment.We describe three cases: acute liver injury, acute liver failure and acute-on-chronic liver failure due to G. esculenta poisoning. At admission patients presented with encephalopathy and features of liver failure. Two of them recovered completely following supportive management while the remaining patient who also had preexisting liver disease developed multiorgan failure and subsequently died.Although a rare occurrence, G. esculenta poisoning should be considered in the differential diagnosis of acute liver failure. 相似文献
53.
ABSTRACT
Introduction
Immune checkpoint inhibitors (ICIs) have proved to be groundbreaking in the field of oncology. However, immune system overactivation from ICIs has introduced a novel medical entity known as immune-related adverse events (irAEs), that can affect any organ or tissue. ICI-induced inflammatory arthritis (ICI-IIA) is the most common musculoskeletal irAE and can lead to significant morbidity and limitation in anti-cancer therapy. 相似文献54.
《Best Practice & Research: Clinical Haematology》2020,33(4):101220
Acute myeloid leukemia (AML) remains a therapeutically challenging malignancy with high rate of relapse and poor outcomes. There has been increased understanding of the molecular characteristics of AML and the various roles of the immune system in its pathogenesis, the result of which has led to the study and development of multiple immune-based approaches for this disease. In this review, we aim to provide an overview of the recent advancements made in antibody-based approaches to the treatment of AML including monoclonal antibodies, antibody-drug conjugates, and immune checkpoint inhibition. In addition, we provide insight and discuss the promise of these agents, some of which may soon enter the therapeutic armamentarium we currently employ against this lethal disease. 相似文献
55.
心力衰竭是一种慢性疾病,是心脏无法泵出足够的血液为其他身体器官提供氧气,从而引发呼吸短促、疲劳和水肿等症状。目前其治疗包括病因治疗、一般治疗、药物治疗及非药物治疗等,其中血管紧张素受体脑啡肽酶抑制剂(ARNI)是当前新研发出的一类抗心衰药物,沙库巴曲缬沙坦是其代表药物,具有阻断肾素-血管紧张-醛固酮系统(RAAS)及抑制脑啡肽酶(NEP)的双重作用,新的欧美指南均推荐用于射血分数降低心力衰竭(HFrEF)的治疗。本文现就沙库巴曲缬沙坦在心力衰竭治疗中的作用机理、临床试验、药物安全性作一综述,旨在为该病的临床治疗提供参考。 相似文献
56.
目的 阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是耳鼻咽喉科的一种常见病,儿童发病率呈上升趋势,调查显示儿童OSAHS发生率为4%~5%,2~6岁是发病的高峰期。OSAHS不仅严重影响儿童的睡眠质量,还会引起儿童生长发育迟缓、智力缺陷等一系列不良反应,OSAHS患儿的主要病因是扁桃体和/或腺样体肥大,因此最有效的治疗方法是扁桃体切除术和腺样体切除术。而扁桃体和腺样体是儿童淋巴组织系统的重要组成部分,在机体的防御和保护功能中发挥着重要作用。手术治疗OSAHS是否影响儿童的免疫功能目前存在争议。一些学者认为扁桃体切除和腺样体切除后儿童的免疫力降低,而另一些学者认为OSAHS儿童的免疫力在手术后保持不变,甚至比手术前有所提高。本文就儿童OSAHS手术前后免疫指标的变化作一综述。 相似文献
57.
58.
59.
Leonardo Jönck Staub Roberta Rodolfo Mazzali Biscaro Erikson Kaszubowski Rosemeri Maurici 《The Journal of emergency medicine》2019,56(1):53-69
Background
Lung ultrasound can accelerate the diagnosis of life-threatening diseases in adults with respiratory symptoms.Objective
Systematically review the accuracy of lung ultrasonography (LUS) for emergency diagnosis of pneumonia, acute heart failure, and exacerbation of chronic obstructive pulmonary disease (COPD)/asthma in adults.Methods
PubMed, Embase, Scopus, Web of Science, and LILACS (Literatura Latino Americana e do Caribe em Ciências da Saúde; until 2016) were searched for prospective diagnostic accuracy studies. Rutter-Gatsonis hierarchical summary receiver operating characteristic method was used to measure the overall accuracy of LUS and Reitsma bivariate model to measure the accuracy of the different sonographic signs. This review was previously registered in PROSPERO (Centre for Reviews and Dissemination, University of York, York, UK; CRD42016048085).Results
Twenty-five studies were included: 14 assessing pneumonia, 14 assessing acute heart failure, and four assessing exacerbations of COPD/asthma. The area under the summary receiver operating characteristic curve of LUS was 0.948 for pneumonia, 0.914 for acute heart failure, and 0.906 for exacerbations of COPD/asthma. In patients suspected to have pneumonia, consolidation had sensitivity of 0.82 (95% confidence interval [CI] 0.74–0.88) and specificity of 0.94 (95% CI 0.85–0.98) for this disease. In acutely dyspneic patients, modified diffuse interstitial syndrome had sensitivity of 0.90 (95% CI 0.87–0.93) and specificity of 0.93 (95% CI 0.91–0.95) for acute heart failure, whereas B-profile had sensitivity of 0.93 (95% CI 0.72–0.98) and specificity of 0.92 (95% CI 0.79–0.97) for this disease in patients with respiratory failure. In patients with acute dyspnea or respiratory failure, the A-profile without PLAPS (posterior-lateral alveolar pleural syndrome) had sensitivity of 0.78 (95% CI 0.67–0.86) and specificity of 0.94 (95% CI 0.89–0.97) for exacerbations of COPD/asthma.Conclusion
Lung ultrasound is an accurate tool for the emergency diagnosis of pneumonia, acute heart failure, and exacerbations of COPD/asthma. 相似文献60.